((2R,3S,4R,5R) -5- (4-Amino-2-oxopyrimidin-1 (2H) -yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl phosphate-13C9,15N3 (sodium)
Selected Variant
HY-W011090S
Size: 1 mg
((2R,3S,4R,5R) -5- (4-Amino-2-oxopyrimidin-1 (2H) -yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl phosphate-13C9,15N3 (sodium) is the 13C and 15N labeled Sodium ((2R,3S,4R,5R) -5- (4-amino-2-oxopyrimidin-1 (2H) -yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl phosphate[1].
Product Specifications
Product Name Alternative
CMP-13C9,15N3
UNSPSC
12352005
Target
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Others
Solubility
10 mM in DMSO
Smiles
O=P(O[Na])(O[Na])O[13CH2][13C@@]1(O[13C@]([H])([15N]2[13CH]=[13CH][13C]([15NH2])=[15N][13C]2=O)[13C]([H])([13C@@]1(O)[H])O)[H]
Molecular Formula
13C9H12 15N3Na2O8P
Molecular Weight
379.07
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog